Related references
Note: Only part of the references are listed.The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed prior infliximab therapy
S. Lichtiger et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Immunogenicity of Anti-TNF-α Agents in Autoimmune Diseases
Nadia Emi Aikawa et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2010)
Survey on the use of adalimumab as maintenance therapy in Crohn's disease in England and Ireland
Evangelos A. Russo et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Adalimumab for Crohn's Disease in Clinical Practice at Mayo Clinic: The First 118 Patients
Jason M. Swoger et al.
INFLAMMATORY BOWEL DISEASES (2010)
Efficacy and complications of adalimumab treatment for medically-refractory Crohn's disease: analysis of nationwide experience in Scotland (2004-2008)
G. T. Ho et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Early clinical experience with adalimumab in treatment of inflammatory bowel disease with infliximab-treated and naive patients
A. Swaminath et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Adalimumab for Crohn's disease with intolerance or lost response to infliximab: a 3-year single-centre experience
A. Oussalah et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Does smoking reduce infliximab's effectiveness against Crohn's disease?
Neeraj Narula et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease
Konstantinos Karmiris et al.
GASTROENTEROLOGY (2009)
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort
F. Schnitzler et al.
GUT (2009)
Mucosal Healing Predicts Long-term Outcome of Maintenance Therapy with Infliximab in Crohn's Disease
Fabian Schnitzler et al.
INFLAMMATORY BOWEL DISEASES (2009)
Mucosal cytokine network in inflammatory bowel disease
Akira Andoh et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
The use of adalimumab in the management of refractory Crohn's disease
G. -T. Ho et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial
W. J. Sandborn et al.
GUT (2007)
Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis
Geertje M. Bartelds et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Adalimumab induction therapy for Crohn disease previously treated with infliximab - A randomized trial
William J. Sandborn et al.
ANNALS OF INTERNAL MEDICINE (2007)
Adalimumab in patients with Crohn's disease -: safety and efficacy in an open-label single centre study
J. Seiderer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Adalimumab maintenance therapy for Crohn's disease with intolerance or lost response to infliximab: an open-label study
L. Peyrin-Biroulet et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial
J. Hinojosa et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry
GR Lichtenstein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial
SB Hanauer et al.
GASTROENTEROLOGY (2006)
Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab
KA Papadakis et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease
P Rutgeerts et al.
GASTROENTEROLOGY (2004)
A pilot study of adalimumab in infliximab-allergic patients
A Youdim et al.
INFLAMMATORY BOWEL DISEASES (2004)
An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease
WJ Sandborn et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Long-term evolution of disease behavior of Crohn's disease
J Cosnes et al.
INFLAMMATORY BOWEL DISEASES (2002)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)